|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
over 14 years ago
Plant Managementover 14 years ago
The Road from No. 20over 14 years ago
Five Yearsover 14 years ago
Spotlight on OTCsover 14 years ago
Invarover 14 years ago
Europe Tackles 'Advertising in Disguise' Fearsover 14 years ago
The Drug Shortages Struggleover 14 years ago
Euroserviceover 14 years ago
Pharma's Visit to the Plastic Surgeonover 14 years ago
The Pharma Revolution RecalibratedAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5